Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients
- 1 March 1994
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 22 (2), 81-85
- https://doi.org/10.1007/bf01739009
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Diagnosing fungal infections in immunocompromised hosts.Journal of Clinical Pathology, 1992
- The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin BJournal of Infection, 1991
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsAmerican Journal Of Medicine, 1989
- Treatment of systemic fungal infections: Recent progress and current problemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of TherapyClinical Infectious Diseases, 1985
- Empiric Amphotericin B Therapy in Patients with Acute LeukemiaClinical Infectious Diseases, 1985
- Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in MiceChemotherapy, 1982
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979